TY - JOUR
T1 - Characterization of methyl-β-cyclodextrin toxicity in NGF-differentiated PC12 cell death
AU - Ulloth, Joel E.
AU - Almaguel, Frankis G.
AU - Padilla, Amelia
AU - Bu, Liming
AU - Liu, Jo Wen
AU - De Leon, Marino
N1 - Funding Information:
We acknowledge Dr. Carlos A. Casiano for advice and discussions and Dr. Sandy Hilliker for reading and helping preparing the manuscript. This study was supported in part by grants NSF IBN-9728662 and NIH awards 5P20MD001632 and 5R25GM060507 to MDL.
PY - 2007/5
Y1 - 2007/5
N2 - Cyclodextrins (CDs) are used to deliver hydrophobic molecules in aqueous environments. Methyl-β-cyclodextrin (MβCD), a member of this family of molecules, has been proposed to be a good carrier to deliver fatty acids to cells in culture. This report focuses on studying the in vitro effects of MβCD on nerve growth factor-differentiated PC12 (NGFDPC12) cells, a tissue culture model to study neuronal survival and differentiation. The main findings are: (1) NGFDPC12 cells have normal viability when exposed to 0.12% MβCD but showed a significant loss in cell viability at higher concentrations; (2) NGFDPC12 cells exposed to 0.25% MβCD exhibit nuclear condensation, blebbing and apoptotic bodies, and whole cell lysates exhibited an increase in caspase-3-like activity and high levels of Bax and Bcl-XL protein expression compared to control. Cultures treated with 0.25% MβCD also showed cleavage of normal 21-kDa Bax protein into a 18-kDa fragment. (3) Experiments using 0.12% MβCD to deliver oleic acid did not affect cell viability, in contrast NGFDPC12 cultures in which 0.25% MβCD concentration is used exhibited similar loss of cell viability as observed with 0.25% MβCD alone. Treating these cultures with caspase-3 inhibitor z-VAD-fmk did not protect the cells from MβCD toxic effects. (4) Immortalized Schwann cells (iSC) exposed to MβCD 0.12% did not show loss of cell viability while 0.25% MβCD triggered a significant toxicity but with a different dose and time course dynamic than NGFDPC12 cells. Thus, NGFDPC12 or iSC cell cultures exposed to 0.12% MβCD exhibits normal viability while higher concentrations increase in cell death and apoptosis. © 2007 Elsevier Inc. All rights reserved.
AB - Cyclodextrins (CDs) are used to deliver hydrophobic molecules in aqueous environments. Methyl-β-cyclodextrin (MβCD), a member of this family of molecules, has been proposed to be a good carrier to deliver fatty acids to cells in culture. This report focuses on studying the in vitro effects of MβCD on nerve growth factor-differentiated PC12 (NGFDPC12) cells, a tissue culture model to study neuronal survival and differentiation. The main findings are: (1) NGFDPC12 cells have normal viability when exposed to 0.12% MβCD but showed a significant loss in cell viability at higher concentrations; (2) NGFDPC12 cells exposed to 0.25% MβCD exhibit nuclear condensation, blebbing and apoptotic bodies, and whole cell lysates exhibited an increase in caspase-3-like activity and high levels of Bax and Bcl-XL protein expression compared to control. Cultures treated with 0.25% MβCD also showed cleavage of normal 21-kDa Bax protein into a 18-kDa fragment. (3) Experiments using 0.12% MβCD to deliver oleic acid did not affect cell viability, in contrast NGFDPC12 cultures in which 0.25% MβCD concentration is used exhibited similar loss of cell viability as observed with 0.25% MβCD alone. Treating these cultures with caspase-3 inhibitor z-VAD-fmk did not protect the cells from MβCD toxic effects. (4) Immortalized Schwann cells (iSC) exposed to MβCD 0.12% did not show loss of cell viability while 0.25% MβCD triggered a significant toxicity but with a different dose and time course dynamic than NGFDPC12 cells. Thus, NGFDPC12 or iSC cell cultures exposed to 0.12% MβCD exhibits normal viability while higher concentrations increase in cell death and apoptosis. © 2007 Elsevier Inc. All rights reserved.
KW - Bax
KW - Bcl-2
KW - Bcl-X
KW - Caspase
KW - Methyl-β-cyclodextrin
KW - Toxicity
KW - Caspase 3/metabolism
KW - Schwann Cells/drug effects
KW - beta-Cyclodextrins/toxicity
KW - Bromodeoxyuridine
KW - Cell Survival/drug effects
KW - Genes, bcl-2/drug effects
KW - PC12 Cells
KW - Flow Cytometry
KW - Cell Nucleus/drug effects
KW - Caspase 7/metabolism
KW - In Situ Nick-End Labeling
KW - Cell Differentiation/drug effects
KW - Oleic Acid/toxicity
KW - Apoptosis/drug effects
KW - Rats
KW - Nerve Growth Factor/genetics
KW - Antimetabolites
KW - Blotting, Western
KW - Animals
KW - Caspase 2/metabolism
UR - http://www.scopus.com/inward/record.url?scp=34249728310&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34249728310&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/8e3927f4-704c-3ec6-9478-ba124ac84c62/
U2 - 10.1016/j.neuro.2007.01.001
DO - 10.1016/j.neuro.2007.01.001
M3 - Article
C2 - 17292476
SN - 0161-813X
VL - 28
SP - 613
EP - 621
JO - NeuroToxicology
JF - NeuroToxicology
IS - 3
ER -